HIGHLIGHTS
- who: Loek A. W. de Jong from the Department of Pharmacy, Radboud University Medical Center Research Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid, , GA Nijmegen, The Netherlands have published the research: Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer, in the Journal: (JOURNAL)
- what: Another important adverse event of intraperitoneal administration are catheter-related complications, including catheter infection, blocked catheter, leaking catheter and port access problems, which is the primary reason for discontinuation of therapy . This study investigated the systemic exposure to both cisplatin and paclitaxel after . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.